Archive for the 'post-hoc' tag

Post Hoc Analysis Indicated That Timing And Magnitude Of Initial Response To Certolizumab Pegol Predicted Likelihood Of Low Disease Activity At Week…

June 8th, 2012 by Dr. Samuel Dyer

BERLIN and BRUSSELS, June 8, 2012 /PRNewswire/...
Read more

Posted in Clinical Trial Results, Pharma Industry Business News | No comments

First Assessment of Individual RLS Domains in New Post-Hoc Analyses of Neupro Studies

April 25th, 2012 by Dr. Samuel Dyer

Data presented at the 64th AAN Annual Meeting...
Read more

Posted in Clinical Trial Results, Pharma Industry Business News | No comments

New Post Hoc Analyses Examined the Effects of Neupro (Rotigotine Transdermal System) on Daytime Functioning, Daytime Symptoms, Pain and Mood in…

June 10th, 2011 by Dr. Samuel Dyer

BRUSSELS, June 10, 2011 /PRNewswire/ —...
Read more

Posted in Clinical Trial Results | No comments

Post Hoc Analysis from RECOVER Study Examined Effects of Neupro (Rotigotine Transdermal System) on Surrogate Markers of Mood and Anhedonia in…

June 9th, 2011 by Dr. Samuel Dyer

? ? BRUSSELS, June 9, 2011 /PRNewswire/ — A...
Read more

Posted in Clinical Trial Results | No comments